Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2010; 16(43): 5395-5404
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5395
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5395
Signaling | Sub categories | Role in inflammation assumed cancer |
Pro-inflammatory cytokines and immunosuppressant cytokines | ILS: Pro-inflammatory (IL-1, IL-6, IL-8, IL-17); immunosuppressor (IL-10); TNF-α plays dual role in carcinogenesis, usually it is tumor promoter | Over expressed in inflamed and hyperplastic, metaplastic tissues and adenocarcinoma; Induce DNA damage; Pro-angiogenic molecule such as VEGF, VEGFR, IL-8, NO, ICAM-1 VCAM-1; Activation of pro-inflammatory signals mediated via JAK-STAT and NF-κB; Maintain inflammatory tumor microenvironment; Stimulate cell proliferation and inhibit apoptosis |
Chemokines | Four major groups: CXC, CC, XC, CX3C (primary function is to recruit leucocytes at the site of inflammation) | Responsible for attraction to inflammatory and immune cells to tumor microenvironment; Promotion of tumor cell migration, facilitation of invasion and metastasis; Stimulation of inflammatory angiogenesis |
COX-2 and prostaglandins | An inducible form of cyclooxygenase, serves as interface between inflammation and cancer[41-44] | Causes promotion of : cellular proliferation, suppression of apoptosis, enhancement of invasiveness, angiogenesis |
iNOS | Expression of iNOS is elevated in various precancerous lesions and carcinomas[45] | Elevated in precancerous and cancerous lesions and cause: DNA damage by nitrosation/oxidative pathways; Produce proinflammatory mediators like NO by catalyzing Arginin metabolism; Acts as a downstream effector of NF-κB and inflammatory cytokines mediated signaling |
NO | Elevated in precancerous and cancerous lesions[46] | Selects mutant p53 cells and contribute to tumorigenesis by upregulating VEGF; DNA damaged by nitrosation of nucleotide bases |
NF-κB (The NF-κB/Rel family of proteins includes CRel, RelA (p65), RelB, NF-κB1 (p50/100), NF-κB2 (p52/p100)[47] | One of the DNA binding proteins that are aberrantly activated in response to inflammatory stimuli leading to induction of transcription of various proinflammatory genes in tumor cells[48] | Enhances expression/production of proinflammatory mediators: Amplifies inflammation signal transduction; Increased expression of anti-apoptotic protein; Help transformed cells to escape apoptosis |
ErbB2 (a receptor strongly involved in carcinogenesis) | Inflammation induces the expression[49-50] | Binding of ErbB1 and ErbB2 to ligands results in prolong activation of intrinsic protein kinase activity, leading to activation of a biochemical cascade responsible for mitogenic cell signal transduction |
Toxin | Source | Activity and outcome |
Potential genotoxins | ||
CDT (three subunits: CdtB is a functional unit, while CdtA and CdtC serve as accessory units for delivery into target cells) | Haemophilus ducreyi, Helicobacter hepaticus, Salmonella typhi. Actinobacillus actinomycetemcomitans | DNAase; DNA damage and cell cycle inhibitor[56,57] |
Cytolethal distending toxin B | Salmonella typhi | DNAase activity, genotoxic by creating DNA lesions[58] |
Colibactin | Escherichia coli | Mechanism unknown[59] |
Potential pro-carcinogenic toxins | ||
Pasturella multocida toxin | Pasturella multocida | Modifies Gq proliferation[60] |
CagA | Helicobacter pylori | Binds to SHP2 and c- Met cells scattering[61] |
Vacuolating cytotoxin A | Helicobacter pylori | Upregulation of VEGF expression (seems to depend on the activation of EGFR, MAP kinase and COX-2 mediated) |
Bacteroides fragilis toxin | Bacteroides fragilis | Cleaves E- cadherin proliferation[62] |
Cytotoxic necrotizing factor-1 | Escherichia coli, Shigella dysenteriae, Campylobacter jejuni and Salmonella typhi, Helicobacter hepaticus, Actinobacillus actinomycetemcomitans | Modifies Rho family proteins, inflammation and inhibition of cell cycle, blocks cytokines[39] |
Cycle inhibiting factor | Escherichia coli | Inhibit cell cycle at G2-M transition[63] |
MAP | Citrobacter rodentium | Multifunctional effectors protein that target host cell mitochondria implicated in the disruption of epithelial barrier function both in vitro and in vivo[64] |
VEGF | Bartonella species | Angiogenesis and proliferation[65] |
Organism | No. of isolates | % |
Aerobic bacteria | ||
Escherichia coli | 71 | 32.9 |
Group D streptococci | 42 | 19.4 |
Klebsiella species | 29 | 15.3 |
Enterobacter species | 26 | 12.5 |
Proteus species | 15 | 6.9 |
α-haemolytic streptococci | 11 | 5.1 |
Citrobacter species | 8 | 3.6 |
Staphylococcus species | 7 | 3.2 |
γ-haemolytic streptococci | 5 | 2.3 |
Pseudomonas species | 2 | 0.9 |
Anaerobic bacteria | ||
Clostridium perfringens | 23 | 29.9 |
Bacteroides fragilis | 9 | 11.7 |
Other Bacteroides species | 5 | 6.5 |
B. thetaiotamicron | 4 | 5.2 |
B. ovatus | 2 | 5.2 |
B. distasonis | 2 | 2.6 |
Propionibacterium acne | 7 | 9.1 |
- Citation: Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol 2010; 16(43): 5395-5404
- URL: https://www.wjgnet.com/1007-9327/full/v16/i43/5395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i43.5395